Recommended for use in adults with an elevated risk for cancer, 40+ or older
Lepu Medical has developed a methylated genes product for lung cancer detection.
Only a tube of blood is needed for the non-invasive diagnostic tests
Describe of Diagnostic Kit for Methylated Genes of Lung Cancer
The Diagnostics kits of methylated genes of lung cancer are relied on a blood-based test and combine with proprietary epigenomics ctDNA methylation biomarkers for diagnosis of lung cancer, also known as abnormal gene epigenetic modification. Lung cancer diagnostic kits as an auxiliary screening technique can alleviate and avoid patient anxiety during times of uncertain results, assist the doctors with a clinical diagnosis of diseases, providing doctors with a fast, accurate, and reliable method to diagnose cancer.
The Diagnostics kits can be used for lung cancer screening by detecting abnormal methylation levels of ctDNA. It can predict the development of cancer and monitor cancer metastasis and recurrence.
The Diagnostics kits can be used at various stages of cancer development.
Population Groups Recommended for Screening
Smoking history (including current or former smokers) or smoke exposure (passive smoking).
Male and female aged 40 and above.
Been diagnosed with a pulmonary nodule.
Been diagnosed with other lung diseases, like chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, etc.
Family history of lung cancer in first-degree relatives.
Occupational exposures (Especially occupations identified as having targeted lung carcinogens).